Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 March 2006 | Volume 144 Issue 5 | Pages 364-367
Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.
Author and Article Information
From University of Toronto, Institute for Evaluative Sciences, Institute for Work and Health, and Toronto General Research Institute, Toronto, Canada; Children's Hospital of Eastern Ontario, Ottawa, Canada; and University of London, London, United Kingdom.
*The members of the CONSORT Group are listed on the following Web site: http://www.consort-statement.org/Profiles/profiles.html.
Acknowledgments: The authors thank Greer Palloo for aiding in the preparation for the June meeting, and Jaime DeMelo, ND, and Cyndi Gilbert for assisting Joel Gagnier, ND, MSc, and Claire Bombardier, MD, during the actual meeting procedures.
Grant Support: This study was funded in part by an operating grant from the Canadian Institutes of Health Research, Clinical Trials Divisions (ATF-66679). Dr. Gagnier is supported by a postgraduate fellowship from the Canadian Institutes of Health Research and the Natural Health Products Directorate.
Potential Financial Conflicts of Interest: Grants received: J. Barnes (Lichtwer Pharma); Grants pending: J. Barnes (Lichtwer Pharma); Royalties: J. Barnes (Pharmaceutical Press, Churchill Livingstone).
Requests for Single Reprints: Joel J. Gagnier, ND, MSc, 5955 Ontario Street, Unit 307, Windsor, Ontario N81S W6, Canada; e-mail, j.gagnier{at}utoronto.ca.
Current Author Addresses: Dr. Gagnier: 5955 Ontario Street, Unit 307, Windsor, Ontario N81S W6, Canada.
Dr. Boon: University of Toronto, Faculty of Pharmacy, 19 Russell Street, Toronto, Ontario M5S 2S2, Canada.
Dr. Rochon: Baycrest Centre, 3560 Bathurst Street, Toronto, Ontario M6A 2E1, Canada.
Dr. Moher: Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Room 210, Ottawa, Ontario K1H 8L1, Canada.
Dr. Barnes: Centre for Pharmacognosy and Phytotherapy, University of London School of Pharmacy, 29/39 Brunswick Square, London WC1N 1AX, United Kingdom.
Dr. Bombardier: Institute for Work and Health, 481 University Avenue, Suite 800, Toronto, Ontario M5G 2E9, Canada. ACADEMIA AND CLINIC
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
![]()
This article has been cited by other articles:
![]() |
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration Ann Intern Med, February 19, 2008; 148(4): 295 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments Ann Intern Med, February 19, 2008; 148(4): W-60 - W-66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Whelan, T. M. Jurgens, and L. Lord Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments Evid. Based Complement. Altern. Med., January 18, 2008; (2008) nem186v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wu, M. Liu, and Y. Fang Response to Letter by Bereczki Stroke, November 1, 2007; 38(11): e143 - e143. [Full Text] [PDF] |
||||
![]() |
E. v. Elm, D. G Altman, M. Egger, S. J Pocock, P. C Gotzsche, J. P Vandenbroucke, and STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ, October 20, 2007; 335(7624): 806 - 808. [Full Text] [PDF] |
||||
![]() |
E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gotzsche, J. P. Vandenbroucke, and for the STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies Ann Intern Med, October 16, 2007; 147(8): 573 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Firenzuoli and L. Gori Herbal Medicine Today: Clinical and Research Issues Evid. Based Complement. Altern. Med., September 1, 2007; 4(suppl_1): 37 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Calapai and A. P. Caputi Herbal Medicines: Can We Do Without Pharmacologist? Evid. Based Complement. Altern. Med., September 1, 2007; 4(suppl_1): 41 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tamayo and S. Diamond Review of Clinical Trials Evaluating Safety and Efficacy of Milk Thistle (Silybum marianum [L.] Gaertn.) Integr Cancer Ther, June 1, 2007; 6(2): 146 - 157. [Abstract] [PDF] |
||||
![]() |
S. M. Sagar Future Directions for Research on Silybum marianum for Cancer Patients Integr Cancer Ther, June 1, 2007; 6(2): 166 - 173. [Abstract] [PDF] |
||||
![]() |
E. M Balk, T. A Horsley, S. J Newberry, A. H Lichtenstein, E. A Yetley, H. M Schachter, D. Moher, C. H MacLean, and J. Lau A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Feigin Herbal Medicine in Stroke: Does It Have a Future? Stroke, June 1, 2007; 38(6): 1734 - 1736. [Full Text] [PDF] |
||||
![]() |
L. L. d. Santos-Neto, M. A. de Vilhena Toledo, P. Medeiros-Souza, and G. A. de Souza The Use of Herbal Medicine in Alzheimer's Disease--A Systematic Review Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 441 - 445. [Abstract] [Full Text] [PDF] |
||||